ADVISORY, March 5, 2015 (GLOBE NEWSWIRE) -- What: Summit Therapeutics PLC (Nasdaq:SMMT), the drug discovery and development company advancing therapies for Duchenne Muscular Dystrophy and C ...

In recent trading, shares of Summit Therapeutics Inc (Symbol: SMMT) have crossed above the average analyst 12-month target price of $35.57, changing hands for $36.70/share. When a stock reaches ...

The week kicked off in style for Summit Therapeutics (NASDAQ:SMMT) with the shares soaring by 56% in Monday’s trading session. To be fair, while those are certainly nice gains, it’s not as if ...

Shares of Summit Therapeutics PLC (SMMT) have gained 2.8% over the past four weeks to close the last trading session at $21.2, but there could still be a solid upside left in the stock if short ...

Fintel reports that on March 21, 2025, Cantor Fitzgerald initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Overweight recommendation. As of March 18, 2025, the average one-year ...

Shares of Summit Therapeutics (NASDAQ: SMMT) have plunged 31% as of 1:23 p.m. ET Friday, following the release of some trial data this morning. Summit has been a tremendous winner over the past ...

Summit Therapeutics PLC (SMMT) closed the last trading session at $25.85, gaining 10.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ...

Shares of lung cancer-focused biotech Summit Therapeutics (NASDAQ: SMMT) rallied 16.6% at its highs of the day before settling into a 10.4% gain on Thursday as of 3:54 p.m. EDT, even though the ...

Below is Validea's guru fundamental report for SUMMIT THERAPEUTICS INC (SMMT). Of the 22 guru strategies we follow, SMMT rates highest using our Small-Cap Growth Investor model based on the ...

Deep-pocketed investors have adopted a bullish approach towards Summit Therapeutics (NASDAQ:SMMT), and it's something market players shouldn't ignore. Our tracking of public options records at ...

Summit Therapeutics plc ( SMMT ) is a biopharmaceutical company that could be an interesting play for investors. That is because, not only does the.